Hadjimichael Andreas
CIK 0001591256 Name as filed on the most recent filing
Filed as Hadjimichael Andreas (47)
98 transaction lines · from 47 filings · filed 2014-07-25 to 2023-06-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-06-26 |
Acrivon Therapeutics, Inc. ACRV |
S, Open-market sale | 16 disposed | 12.93 | 206.88 | Form 4, filing 0001213900-23-052442 | |
| 2023-06-15 |
Acrivon Therapeutics, Inc. ACRV |
S, Open-market sale | 2,056 disposed | 12.14 | 24,959.84 | Form 4, filing 0001213900-23-050160 | |
| 2023-06-14 |
Acrivon Therapeutics, Inc. ACRV |
S, Open-market sale | 893 disposed | 12.13 | 10,832.09 | Form 4, filing 0001213900-23-049014 | |
| 2023-06-13 |
Acrivon Therapeutics, Inc. ACRV |
S, Open-market sale | 3,000 disposed | 12.30 | 36,900.00 | Form 4, filing 0001213900-23-049014 | |
| 2023-06-12 |
Acrivon Therapeutics, Inc. ACRV |
S, Open-market sale | 2,000 disposed | 12.34 | 24,680.00 | Form 4, filing 0001213900-23-049014 | |
| 2022-11-17 |
Acrivon Therapeutics, Inc. ACRV |
P, Open-market purchase | 400,000 acquired | 12.50 | 5,000,000.00 | Form 4, filing 0001213900-22-074313 | |
| 2019-02-28 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 149,624 disposed | 4.14 | 619,114.19 | Form 4, filing 0001213900-19-003551 | |
| 2019-02-27 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 558,243 disposed | 4.51 | 2,515,833.73 | Form 4, filing 0001213900-19-003242 | |
| 2019-02-26 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 123,400 disposed | 5.00 | 617,209.78 | Form 4, filing 0001213900-19-003242 | |
| 2019-02-25 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 800,000 disposed | 4.99 | 3,994,880.00 | Form 4, filing 0001213900-19-003242 | |
| 2018-09-06 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 4,800 disposed | 20.52 | 98,473.92 | Form 4, filing 0001213900-18-012296 | |
| 2018-09-05 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 160,000 disposed | 21.06 | 3,370,256.00 | Form 4, filing 0001213900-18-012296 | |
| 2018-09-04 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 40,000 disposed | 20.60 | 824,072.00 | Form 4, filing 0001213900-18-012091 | |
| 2018-08-31 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 11,468 disposed | 21.05 | 241,395.67 | Form 4, filing 0001213900-18-012091 | |
| 2018-08-30 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 200,000 disposed | 21.00 | 4,199,900.00 | Form 4, filing 0001213900-18-012091 | |
| 2018-08-29 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 200,000 disposed | 19.59 | 3,918,280.00 | Form 4, filing 0001213900-18-011892 | |
| 2018-08-27 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 14,026 disposed | 18.52 | 259,775.55 | Form 4, filing 0001213900-18-011892 | |
| 2018-08-10 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 702 disposed | 18.50 | 12,987.00 | Form 4, filing 0001213900-18-011094 | |
| 2018-08-09 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 67,474 disposed | 18.51 | 1,248,781.80 | Form 4, filing 0001213900-18-010635 | |
| 2018-08-08 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 2,800 disposed | 18.61 | 52,098.48 | Form 4, filing 0001213900-18-010635 | |
| 2018-08-07 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 10,602 disposed | 18.60 | 197,197.20 | Form 4, filing 0001213900-18-010635 | |
| 2018-07-25 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 895 disposed | 18.52 | 16,571.01 | Form 4, filing 0001213900-18-009659 | |
| 2018-07-24 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 9,144 disposed | 18.63 | 170,341.75 | Form 4, filing 0001213900-18-009659 | |
| 2018-07-23 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 20,000 disposed | 18.66 | 373,222.00 | Form 4, filing 0001213900-18-009659 | |
| 2018-07-20 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 26,742 disposed | 19.21 | 513,804.74 | Form 4, filing 0001213900-18-009536 | |
| 2018-07-19 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 100,000 disposed | 18.90 | 1,889,940.00 | Form 4, filing 0001213900-18-009536 | |
| 2018-07-18 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 30,000 disposed | 18.53 | 556,005.00 | Form 4, filing 0001213900-18-009395 | |
| 2018-07-17 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 17,346 disposed | 18.50 | 320,901.00 | Form 4, filing 0001213900-18-009395 | |
| 2018-07-16 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 2,654 disposed | 18.52 | 49,160.84 | Form 4, filing 0001213900-18-009395 | |
| 2016-06-23 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 18,824 disposed | 8.03 | 151,083.31 | Form 4, filing 0001213900-16-014500 | |
| 2016-06-13 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 7,074 disposed | 8.51 | 60,213.89 | Form 4, filing 0001213900-16-014246 | |
| 2016-06-09 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 30,000 disposed | 9.14 | 274,098.00 | Form 4, filing 0001213900-16-014152 | |
| 2016-06-08 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 15,541 disposed | 9.34 | 145,185.58 | Form 4, filing 0001213900-16-014152 | |
| 2016-06-07 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 20,000 disposed | 9.25 | 185,086.00 | Form 4, filing 0001213900-16-014107 | |
| 2016-06-06 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 20,000 disposed | 9.22 | 184,464.00 | Form 4, filing 0001213900-16-014107 | |
| 2016-06-02 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 17,855 disposed | 9.65 | 172,243.61 | Form 4, filing 0001213900-16-014045 | |
| 2016-06-01 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 17,568 disposed | 9.64 | 169,327.41 | Form 4, filing 0001213900-16-013967 | |
| 2016-05-31 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 17,096 disposed | 9.66 | 165,072.14 | Form 4, filing 0001213900-16-013967 | |
| 2016-05-27 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 40,000 disposed | 9.58 | 383,200.00 | Form 4, filing 0001213900-16-013967 | |
| 2016-05-26 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 18,182 disposed | 9.59 | 174,287.20 | Form 4, filing 0001213900-16-013868 | |
| 2016-05-25 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 27,940 disposed | 9.83 | 274,541.23 | Form 4, filing 0001213900-16-013868 | |
| 2016-05-23 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 33,932 disposed | 8.76 | 297,413.98 | Form 4, filing 0001213900-16-013765 | |
| 2016-05-20 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 40,000 disposed | 8.52 | 340,748.00 | Form 4, filing 0001213900-16-013765 | |
| 2016-05-19 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 20,000 disposed | 8.18 | 163,644.00 | Form 4, filing 0001213900-16-013765 | |
| 2016-05-18 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 30,000 disposed | 8.15 | 244,488.00 | Form 4, filing 0001213900-16-013630 | |
| 2016-05-17 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 33,800 disposed | 8.15 | 275,480.14 | Form 4, filing 0001213900-16-013630 | |
| 2016-05-16 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 10,000 disposed | 8.01 | 80,065.00 | Form 4, filing 0001213900-16-013570 | |
| 2016-05-13 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 400 disposed | 8.01 | 3,203.48 | Form 4, filing 0001213900-16-013570 | |
| 2016-05-11 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 11,868 disposed | 8.41 | 99,859.73 | Form 4, filing 0001213900-16-013228 | |
| 2016-05-10 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 20,000 disposed | 8.14 | 162,788.00 | Form 4, filing 0001213900-16-013228 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Hadjimichael Andreas, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001591256
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6